REVIUM RECOVERY INC (RVRC) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RVRC SEC filings page.
This page shows REVIUM RECOVERY INC (RVRC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Revium Rx. shows a large reported loss against a modest asset base, while short-term balance-sheet coverage remains comparatively broad.
The unusual scale is the combination of a$13.4M net loss with only$8.3M of assets. That produces ROA of-162.0% and ROE of-195.5% , indicating the reported loss materially exceeded the capital base rather than merely reducing annual earnings. Missing revenue and cash-flow measures prevent judging sales economics or whether the accounting loss translated into cash demands.
The balance sheet is not primarily debt-funded: total liabilities were
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
REVIUM RECOVERY INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
REVIUM RECOVERY INC's EBITDA was -$732K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. Against the prior quarter it is up 0.7%.
REVIUM RECOVERY INC reported -$748K in net income in Q2 2026. This represents an increase of 28.0% from the same quarter a year earlier. Against the prior quarter it is down 3.2%.
REVIUM RECOVERY INC earned $0.01 per diluted share (EPS) in Q2 2026. This represents a decrease of 50.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Cash & Balance Sheet
REVIUM RECOVERY INC held $842K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
REVIUM RECOVERY INC's ROE was -13.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 7.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
REVIUM RECOVERY INC invested $443K in research and development in Q2 2026. This represents an increase of 13.3% from the same quarter a year earlier. Against the prior quarter it is down 6.3%.
Not reported for Q2 2026.
Not reported for Q2 2026.
RVRC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| R&D Expenses | $443K+13.3% | $473K+117.0% | N/A | $391K | $218K | N/A |
| SG&A Expenses | $289K-47.2% | $266K-48.7% | N/A | $547K | $519K | N/A |
| Operating Income | -$732K+22.0% | -$739K-0.3% | N/A | -$938K | -$737K | N/A |
| EBITDA | -$732K | -$737K | N/A | N/A | N/A | N/A |
| Net Income | -$748K+28.0% | -$725K-14.4% | N/A | -$1.0M | -$634K | N/A |
| EPS (Basic) | $0.01-50.0% | $0.010.0% | N/A | $0.02 | $0.01 | N/A |
| EPS (Diluted) | $0.01-50.0% | $0.010.0% | N/A | $0.02 | $0.01 | N/A |
| Diluted Shares (Avg) | 61M0.0% | 61M0.0% | N/A | 61M | 61M | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
RVRC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| Total Assets | $7.1M | $7.8M | $8.3M-59.1% | N/A | N/A | $20.3M |
| Current Assets | $1.9M | $2.5M | $3.1M-43.9% | N/A | N/A | $5.5M |
| Cash & Equivalents | $842K-76.9% | $920K-76.5% | $1.7M-48.7% | $3.6M | $3.9M | $3.3M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $2.6M | $2.6M | $2.6M-77.4% | N/A | N/A | $11.4M |
| Total Liabilities | $1.6M | $1.6M | $1.4M+146.5% | N/A | N/A | $576K |
| Current Liabilities | $971K | $1.5M | $799K+38.7% | N/A | N/A | $576K |
| Non-Current Liabilities | $619K | $67K | $621K | N/A | N/A | $0 |
| Total Equity | $5.5M-70.2% | $6.2M-68.3% | $6.9M-65.1% | $18.5M | $19.4M | $19.7M |
| Retained Earnings | -$26.4M | -$25.7M | -$25.0M-116.8% | N/A | N/A | -$11.5M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.
RVRC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
RVRC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| REVIUM RECOVERY INC RVRC | FY2025 | N/A | -$13.4M | N/A | $86.8M | — |
| RENALYTIX PLC SP/ADR RNLXY | FY2024 | $2.3M | -$33.5M | N/A | $50.1M | — |
| RETRIEVE MEDICAL HLDG INC RMHI | FY2022 | N/A | -$165K | N/A | $29.2M | — |
Where REVIUM RECOVERY INC Ranks
Frequently Asked Questions
Is REVIUM RECOVERY INC profitable?
No, REVIUM RECOVERY INC (RVRC) reported a net income of -$13.4M in fiscal year 2025.
What is REVIUM RECOVERY INC's return on equity (ROE)?
REVIUM RECOVERY INC (RVRC) has a return on equity of -195.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What are REVIUM RECOVERY INC's total assets?
REVIUM RECOVERY INC (RVRC) had $8.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What is REVIUM RECOVERY INC's current ratio?
REVIUM RECOVERY INC (RVRC) had a current ratio of 3.87 as of fiscal year 2025, which is generally considered healthy.
What is REVIUM RECOVERY INC's debt-to-equity ratio?
REVIUM RECOVERY INC (RVRC) had a debt-to-equity ratio of 0.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is REVIUM RECOVERY INC's return on assets (ROA)?
REVIUM RECOVERY INC (RVRC) had a return on assets of -162.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.